{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:15:24Z","timestamp":1782202524769,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2198,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/mt.2010.144","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T12:19:16Z","timestamp":1279628356000},"page":"1837-1845","source":"Crossref","is-referenced-by-count":45,"title":["A Therapeutic Strategy for Choroidal Neovascularization Based on Recruitment of Mesenchymal Stem Cells to the Sites of Lesions"],"prefix":"10.1016","volume":"18","author":[{"given":"Hui-Yuan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.144_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clinbiochem.2005.11.013","article-title":"Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions","volume":"39","author":"Tong","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1038\/mt.2010.144_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","article-title":"Choroidal neovascularization","volume":"137","author":"Grossniklaus","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1038\/mt.2010.144_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.molmed.2007.06.005","article-title":"Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts","volume":"13","author":"No\u00ebl","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2010.144_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","article-title":"Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies","volume":"48","author":"Ambati","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1038\/mt.2010.144_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mvr.2007.04.011","article-title":"Retinal and choroidal microangiopathies: therapeutic opportunities","volume":"74","author":"Afzal","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1038\/mt.2010.144_bib6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1582-4934.2007.00120.x","article-title":"Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors","volume":"11","author":"Ball","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1038\/mt.2010.144_bib7","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1089\/ten.2006.12.2875","article-title":"Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation","volume":"12","author":"Ghajar","year":"2006","journal-title":"Tissue Eng"},{"key":"10.1038\/mt.2010.144_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mvr.2007.06.003","article-title":"The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions","volume":"75","author":"Liu","year":"2008","journal-title":"Microvasc Res"},{"key":"10.1038\/mt.2010.144_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1634\/stemcells.2007-0737","article-title":"The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury","volume":"26","author":"Oh","year":"2008","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2010.144_bib10","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2010.144_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2007.12.008","article-title":"Cell and gene therapy using mesenchymal stem cells (MSCs)","volume":"30","author":"Ozawa","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1038\/mt.2010.144_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents","volume":"96","author":"Studeny","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2010.144_bib13","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1111\/j.1582-4934.2008.00317.x","article-title":"Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model","volume":"12","author":"Mohr","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1038\/mt.2010.144_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-540-68976-8_12","article-title":"The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles","volume":"180","author":"Hall","year":"2007","journal-title":"Handb Exp Pharmacol"},{"key":"10.1038\/mt.2010.144_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jgm.840","article-title":"Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model","volume":"8","author":"Kyriakou","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2010.144_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1634\/stemcells.22-1-21","article-title":"Choroidal neovascularization is provided by bone marrow cells","volume":"22","author":"Tomita","year":"2004","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2010.144_bib17","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1167\/iovs.03-0342","article-title":"The role of adult bone marrow-derived stem cells in choroidal neovascularization","volume":"44","author":"Sengupta","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.144_bib18","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1167\/iovs.03-0371","article-title":"Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.144_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2004.05.177","article-title":"Contribution of bone-marrow-derived cells to choroidal neovascularization","volume":"320","author":"Takahashi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2010.144_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.exer.2004.10.005","article-title":"Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization","volume":"80","author":"Espinosa-Heidmann","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib21","first-page":"1994","article-title":"AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization","volume":"43","author":"Mori","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.144_bib22","first-page":"2428","article-title":"Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor","volume":"43","author":"Mori","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.144_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2005.07.025","article-title":"Rationale for combination therapies for choroidal neovascularization","volume":"141","author":"Spaide","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1038\/mt.2010.144_bib24","first-page":"747","article-title":"Choroidal neovascularization: a wound healing perspective","volume":"9","author":"Kent","year":"2003","journal-title":"Mol Vis"},{"key":"10.1038\/mt.2010.144_bib25","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","article-title":"The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization","volume":"21","author":"Lima e Silva","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/mt.2010.144_bib26","doi-asserted-by":"crossref","first-page":"15554","DOI":"10.1074\/jbc.M602003200","article-title":"Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1","volume":"281","author":"Okuyama","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.144_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.exer.2004.01.010","article-title":"Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor","volume":"78","author":"Csaky","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1582-4934.2007.00001.x","article-title":"Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system","volume":"11","author":"Docheva","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1038\/mt.2010.144_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1532\/IJH97.06230","article-title":"Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles","volume":"86","author":"Hall","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1038\/mt.2010.144_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exer.2005.05.007","article-title":"Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration","volume":"82","author":"Bhutto","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib31","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jcb.21748","article-title":"PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts","volume":"104","author":"Sarojini","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1038\/mt.2010.144_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.1.02008","article-title":"Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy","volume":"37","author":"Zhang","year":"2006","journal-title":"J Mol Endocrinol"},{"key":"10.1038\/mt.2010.144_bib33","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1167\/iovs.04-0172","article-title":"Stimulation of neovascularization by the anti-angiogenic factor PEDF","volume":"45","author":"Apte","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.144_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.exer.2005.10.016","article-title":"Focus on molecules: pigment epithelium-derived factor (PEDF)","volume":"82","author":"Becerra","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.preteyeres.2004.05.002","article-title":"Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential","volume":"23","author":"Barnstable","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1038\/mt.2010.144_bib36","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.1074\/jbc.M600353200","article-title":"Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor","volume":"281","author":"Notari","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.144_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exer.2003.10.013","article-title":"Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution","volume":"78","author":"Becerra","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.preteyeres.2008.05.002","article-title":"The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration","volume":"27","author":"Grisanti","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1038\/mt.2010.144_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2010.144_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1038\/mt.2010.144_bib41","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","article-title":"Potential risks of bone marrow cell transplantation into infarcted hearts","volume":"110","author":"Breitbach","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2010.144_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/02713680601100459","article-title":"The dynamic conduct of bone marrow-derived cells in the choroidal neovascularization microenvironment","volume":"31","author":"Hou","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1038\/mt.2010.144_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.exer.2008.03.018","article-title":"Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice","volume":"86","author":"Hou","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1038\/mt.2010.144_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization","volume":"188","author":"Mori","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1038\/mt.2010.144_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/10807680260218542","article-title":"Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells","volume":"18","author":"Wang","year":"2002","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T07:51:23Z","timestamp":1544341883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616308681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1525001616308681"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.144","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}